Compare DVAX & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVAX | YELP |
|---|---|---|
| Founded | 1996 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2004 | 2012 |
| Metric | DVAX | YELP |
|---|---|---|
| Price | $15.50 | $24.41 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $26.50 | ★ $31.60 |
| AVG Volume (30 Days) | ★ 2.6M | 1.1M |
| Earning Date | 02-20-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.30 |
| EPS | N/A | ★ 2.25 |
| Revenue | $330,514,000.00 | ★ $1,466,918,000.00 |
| Revenue This Year | $24.63 | $5.73 |
| Revenue Next Year | $15.85 | $2.81 |
| P/E Ratio | ★ N/A | $10.87 |
| Revenue Growth | ★ 26.73 | 5.34 |
| 52 Week Low | $9.20 | $23.92 |
| 52 Week High | $15.73 | $41.22 |
| Indicator | DVAX | YELP |
|---|---|---|
| Relative Strength Index (RSI) | 76.15 | 24.08 |
| Support Level | $15.46 | $23.92 |
| Resistance Level | $15.59 | $27.65 |
| Average True Range (ATR) | 0.06 | 0.93 |
| MACD | -0.16 | -0.41 |
| Stochastic Oscillator | 15.22 | 9.27 |
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.